Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: clinicaltrials.gov
Heat From FDAAA: Time For New GPP
Good Publication Practice, or GPP, is often the first port-of-call for companies publishing in the biomedical sector.
But consider this. The first ideas for GPP were formed a decade ago, and now the time is right for GPP2: the new, revised Good Publication Practice.
Why now? Pharma publication practice is a hot potato. Purported cases of publication-related [...]
Posted in Regulatory Also tagged Chris Graf, FDAAA, GPP, ICMJE, ISMPP, Publication Planning, Steering Committee Leave a comment

Pfizer to Launch Clinical Trial Network